Neurological Disorders

Migraine drug pipeline

  • ICD-11 8A80
  • MeSH D008881

2 compounds from 2 companies are in active clinical development for migraine.

2Compounds
2Companies
0Phase 3+
88Trials recruiting

Mechanisms: Small molecule (1) · Peptide (1)

Pipeline data compiled September 2026 · every fact sourced.

Upcoming readouts & recent results

  • 2025-06-04ReportedBHV-2100Topline datamissedNCT06603623

    Phase 2 acute migraine trial of BHV-2100 detects no efficacy signal on the 2-hour pain-freedom and MBS co-primary endpoints

  • 2025-02-25ReportedTNX-1900Topline datamissed

    Phase 2 chronic migraine study of TNX-1900 failed: both doses numerically worse than placebo on monthly migraine days; results disclosed only via ClinicalTrials.gov

See the full catalyst calendar →

Compounds in development (2)

CompoundCompanyPhaseStatusMechanism
BHV-2100Biohaven Ltd.Phase 2ActiveTRPM3 Antagonist
TNX-1900Tonix Pharmaceuticals Holding Corp.DiscontinuedDiscontinuedOxytocin receptor Agonist

Trials recruiting now (83)

83 drug-interventional migraine trials recruiting now, of 823 registered interventional trials. Browse all on ClinicalTrials.gov →

Showing the 12 most advanced of 83 recruiting drug trials · see all on ClinicalTrials.gov →

Frequently asked

How many drugs are in development for migraine?
2 compounds from 2 companies are in active clinical development for migraine.
How many clinical trials are recruiting for migraine?
83 drug-interventional migraine trials are currently recruiting participants, out of 823 registered interventional trials.